Macular degeneration is one of the leading causes of blindness in people over the age of 60 and a trans-Atlantic study may have found the culprit behind this problem. Researchers from the University of Southampton in the UK and the University of Iowa in the USA believe the Serping 1 gene is responsible for age-related macular degeneration (AMD). This discovery is expected to help scientists find better treatments and improve screening processes for patients. The finding was recently published in the on-line version of The Lancet.
The researchers found the gene in 25% of the people participating in the study. Past data have indicated that almost 66% of octogenarians suffer from AMD and over 10% are left blind by the disease. The area at the back of the eye is what helps people see objects in fine detail. AMD affects this area. The researchers postulate that 33% of the population over the age of 75 will eventually suffer from AMD.
The Southampton team said the annual economic burden from the disease could reach L80.0 million ($125.5 million) in the UK alone. According to the researchers, this figure could rise as the number of older people grows. The research also showed that the costs of healthcare increased seven-fold for AMD sufferers versus non-AMD patients.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze